INFU Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
37.6M
+1.8%
36.9M
+9.6%
33.7M
-7.0%
36.2M
-0.7%
36.5M
Cost of Revenue
15.9M
+2.2%
15.5M
+10.8%
14.0M
-11.4%
15.8M
+0.8%
15.7M
Gross Profit
21.7M
+1.5%
21.4M
+8.8%
19.7M
-3.7%
20.4M
-1.8%
20.8M
Operating Expenses
17.0M
-1.6%
17.3M
-4.6%
18.1M
+8.2%
16.7M
-1.7%
17.0M
R&D
0
0
0
0
0
SG&A
16.8M
-1.6%
17.1M
-4.5%
17.9M
+8.3%
16.5M
-1.7%
16.8M
Operating Income
4.7M
+14.3%
4.2M
+161.1%
1.6M
-57.2%
3.7M
-2.5%
3.8M
EBITDA
7.9M
+7.4%
7.3M
+51.3%
4.8M
-31.4%
7.1M
-0.5%
7.1M
Net Income
3.2M
-2.3%
3.2M
+217.7%
1.0M
-50.0%
2.0M
-9.9%
2.3M
EPS (Basic)
$0.16
+0.0%
$0.16
+220.0%
$0.05
-50.0%
$0.10
-9.1%
$0.11
EPS (Diluted)
$0.15
+0.0%
$0.15
+200.0%
$0.05
-50.0%
$0.10
-9.1%
$0.11
Shares (Diluted)
21.1M
+0.7%
20.9M
+0.1%
20.9M
-1.7%
21.3M
+1.5%
20.9M
InfuSystem (INFU) — Financials